NCT06523530View on ClinicalTrials.gov

Effect of a GnRH Analog on Hepatic Steatosis

PHASE4RecruitingINTERVENTIONAL
Enrollment

62

Participants

Timeline

Start Date

November 26, 2024

Primary Completion Date

October 31, 2026

Study Completion Date

April 30, 2027

Conditions
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Interventions
DRUG

Goserelin Acetate 3.6 mg inj, implant

3.6 mg (1ml) administered subcutaneously once every month for 6 months (totally 6 injections)

Trial Locations (2)

56403

RECRUITING

1st Department of Obstetrics and Gynecology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki

56429

RECRUITING

424 General Military Hospital, Thessaloniki

All Listed Sponsors
collaborator

424 General Military Hospital

OTHER

lead

Aristotle University Of Thessaloniki

OTHER